Skip to content

FTH - Faeth Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchF

Faeth Therapeutics, Inc.

FTH · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

F

FTHFaeth Therapeutics, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $37.90
52-wk low: $7.45
Prev close: $22.57
Mkt cap: $855.6M
Beta: -0.31
P/B: 4.9x

Smart money

Checking federal contract awards

Coverage gaps for FTH

No tracked fund holdings this quarter
No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings

Reported Aug 4, 2026

Earnings came in $1.74 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $856M

Valuation

P/B4.92

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: FTH
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $855.58M
Beta: -0.31

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-195.3%

10-K

Earnings per share

-$2.84-$1.74

-$1.10 expected

Next report

What the street expects next

-195.3%

ROA-20.8%

Growth

Beta-0.31